Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano
Authors:
- Bianca BartocciBBBianca Bartocci
- Arianna Dal BuonoABArianna Dal Buono
- Roberto GabbiadiniRGRoberto Gabbiadini
- Anita BusaccaABAnita Busacca
- Alessandro QuadarellaAQAlessandro Quadarella
- Alessandro RepiciARAlessandro Repici
- Emanuela MencagliaEMEmanuela Mencaglia
- Linda GaspariniLGLinda Gasparini
- Alessandro ArmuzziAlessandro Armuzzi
Open Access
Abstract
Background and aims: Inflammatory bowel diseases (IBD) are chronic disorders associated with a reduced quality of life, and patients often also suffer from psychiatric comorbidities. Overall, both mood and cognitive disorders are prevalent in chronic organic diseases, especially in the case of a strong immune component, such as rheumatoid arthritis, multiple sclerosis, and cancer. Divergent data regarding the true incidence and prevalence of mental disorders in patients with IBD are available. We aimed to review the current evidence on the topic and the burden of mental illness in IBD patients, the role of the brain–gut axis in their co-existence, and its implication in an integrated clinical management. Methods: PubMed was searched to identify relevant studies investigating the gut–brain interactions and the incidence and prevalence of psychiatric disorders, especially of depression, anxiety, and cognitive dysfunction in the IBD population. Results: Among IBD patients, there is a high prevalence of psychiatric comorbidities, especially of anxiety and depression. Approximately 20–30% of IBD patients are affected by mood disorders and/or present with anxiety symptoms. Furthermore, it has been observed that the prevalence of mental illnesses increases in patients with active intestinal disease. Psychiatric comorbidities continue to be under-diagnosed in IBD patients and remain an unresolved issue in the management of these patients. Conclusions: Psychiatric illnesses co-occurring in IBD patients deserve acknowledgment from IBD specialists. These comorbidities highly impact the management of IBD patients and should be studied as an adjunctive therapeutic target.Keywords
This publication has 82 references indexed in Scilit:
- Psychiatric co‐morbidity is associated with increased risk of surgery in Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2013
- Immune–neural connections: how the immune system’s response to infectious agents influences behaviorJournal of Experimental Biology, 2013
- Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology, 2012
- INSPIRE study: Does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or crohnʼs disease? A randomized controlled trialInflammatory Bowel Diseases, 2011
- Psychological interventions for treatment of inflammatory bowel diseaseCochrane Database of Systematic Reviews, 2011
- Predictors of persistence with 5‐aminosalicylic acid therapy for ulcerative colitisAlimentary Pharmacology & Therapeutics, 2009
- Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depressionJournal of Clinical Investigation, 2008
- Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokinesNeuroscience, 2005
- Psychiatric Predictors of Noncompliance in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 2001
- Psychosocial aspects of inflammatory bowel diseaseBiomedicine & Pharmacotherapy, 2000